-
Horizon Pharma (HZNP) 'Disappointed' in Depomed's (DEPO) Poison Pill Provision
-
Horizon Pharma (HZNP) Proposes to Acquire Depomed (DEPO) for $29.25/Share
-
Notable Analyst Rating Changes 4/22: (NOK) (MAS) (PKG) Upgraded; (AGU) (RF) (CMG) Downgraded
-
Market Wrap: Target Says 'Adios' to Canada; Bank Profits Clipped on Costs; CHF Minimums Pulled
-
Unusual 11 Mid-Day Movers 10/14: (USU) (SHZ) (ATPG) Higher; (AVII) (NCMI) (DEPO) Lower
-
Morning Movers 10/14: (SHZ) (LOCM) (NAV) (AVL) Higher; (DEPO) (NCMI) (AVII) (INSM) Lower
-
Loeb's Third Point Hedge Fund Gets Out of Citigroup (C), Shows New Stakes in CBS (CBS) and eBay (EBAY) Among Others
-
George Soros' Hedge Fund Slashes Stake In Gold ETF (GLD), Raises Stake in Citi (C) and AT&T (T)
-
Loeb's Third Point Jumps Into BofA, Citi, Comcast, Yahoo!, Sells Out of Amedisys, Northern Trust (BAC) (C) (YHOO) (AMED)
-
Unusual 11 Mid-Day Movers 01/31: DEPO, SSN, DBLE, NPSP, ASIA, LNG Higher; IPCI, BGP, TGA, CHKE, REDF Lower
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
-
Morning Movers 3/6: Wells Fargo (WFC) Up On Dividend Cut, FairPoint (FRP) Slammed On Results
-
Loeb's Third Point 13F; Shows New Stakes in BUD, C, CVS, MER, WEN, UST, Sells Out of MA
-
Pre-Open Movers 2/12: GMH Communities (GCT) Surges On Buyout Deal, Zoltek (ZOLT) Sinks On Results

